Flow Diverter Performance in Aneurysms Arising From the Posterior Communicating Artery: A Systematic Review and Meta-Analysis

医学 动脉瘤 后交通动脉 荟萃分析 闭塞 外科 子群分析 放射科 内科学
作者
Juan Vivanco‐Suarez,Aarón Rodríguez-Calienes,Peter Kan,Ajay K. Wakhloo,Vítor Mendes Pereira,Ricardó A. Hanel,Demetrius K. Lopes,Milagros Galecio‐Castillo,Susan Anil,Mudassir Farooqui,Ajit S Puri,Santiago Ortega‐Gutiérrez
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
卷期号:93 (4): 764-772 被引量:8
标识
DOI:10.1227/neu.0000000000002517
摘要

BACKGROUND: Flow diverters (FDs) have demonstrated a safe and effective profile. However, the use of FDs for posterior communicating artery (PComA) aneurysms remains controversial. OBJECTIVE: To evaluate the safety and effectiveness of FDs for PComA aneurysms using a systematic review and meta-analysis of the literature. METHODS: We performed a systematic search from inception until June 2022 for flow diversion in PComA aneurysms. Primary effectiveness was the rate of complete aneurysm occlusion defined by Raymond-Roy class 1. Primary safety outcomes were treatment-related ischemic/hemorrhagic (composite) events causing morbidity and mortality. Secondary safety was PComA patency at follow-up. Random-effects meta-analyses were used to calculate proportions, and statistical heterogeneity was assessed. RESULTS: A total of 13 studies with 397 patients harboring 403 aneurysms were included. Mean age was 48 years, and the mean aneurysm size was 5.3 mm. Most aneurysms were unruptured (65%). Complete occlusion at final follow-up was 73% (CI 66%-79%), and adjunctive coils were used in 10% of aneurysms. Retreatment rate was 2% (CI 0%-9%). The primary safety composite outcome was 4% (CI 3%-7%), and mortality was 1%. PComA patency at final follow-up was 76% (CI 57%-89%). Subgroup analysis, patients with fetal PComAs had a lower complete occlusion rate (42% fetal PComA vs 77%, p subgroup difference = <.01). CONCLUSION: The performance of FDs in PComA aneurysms is comparable with outcomes found in other subtypes of supraclinoid aneurysms. Effectiveness was acceptable and safety favorable. However, effectiveness was suboptimal in patients with fetal-type PComAs; alternative treatments should be considered in these cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
why完成签到,获得积分10
刚刚
做不了一点科研完成签到 ,获得积分10
刚刚
清爽的冬寒完成签到 ,获得积分10
2秒前
碎落星沉完成签到,获得积分10
2秒前
优雅盼海完成签到,获得积分10
2秒前
2秒前
dx完成签到,获得积分10
2秒前
专注灵凡完成签到,获得积分10
3秒前
Yang完成签到 ,获得积分10
3秒前
高高梦山完成签到 ,获得积分10
3秒前
小魏完成签到,获得积分10
3秒前
728完成签到,获得积分10
4秒前
七子完成签到,获得积分10
4秒前
油麦菜完成签到 ,获得积分10
5秒前
5秒前
小背包完成签到 ,获得积分10
6秒前
zzx396完成签到,获得积分0
6秒前
6秒前
复杂的凝冬完成签到,获得积分10
7秒前
Hello应助科研通管家采纳,获得10
8秒前
debu9完成签到,获得积分10
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
故酒应助科研通管家采纳,获得10
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
大个应助科研通管家采纳,获得10
8秒前
故酒应助科研通管家采纳,获得10
8秒前
普鲁卡因完成签到,获得积分10
8秒前
墨痕mohen完成签到,获得积分10
9秒前
YJL完成签到 ,获得积分10
9秒前
Muhi完成签到,获得积分10
9秒前
Jackson发布了新的文献求助10
10秒前
小文发布了新的文献求助10
10秒前
Titi完成签到 ,获得积分10
11秒前
慕青应助77采纳,获得10
12秒前
陈里里完成签到 ,获得积分10
13秒前
三眼乌鸦发布了新的文献求助10
13秒前
开朗咖啡完成签到,获得积分10
13秒前
16秒前
橘子树完成签到,获得积分10
16秒前
Ice_zhao完成签到,获得积分10
17秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3815945
求助须知:如何正确求助?哪些是违规求助? 3359450
关于积分的说明 10402728
捐赠科研通 3077293
什么是DOI,文献DOI怎么找? 1690285
邀请新用户注册赠送积分活动 813693
科研通“疑难数据库(出版商)”最低求助积分说明 767743